REVA PHARMA, is a fully integrated Healthcare and Pharmaceutical organization. Licensing, Product Development, Contract Manufacturing and Healthcare Services form the main activities of the company. Its operations and initiatives are backed up by regulatory approved infrastructure, which help to offer its partners, Products & Services complying with cGMP, GLP & EHS standards. It has carved out a name for itself in the Healthcare space across geographies for Reliability, Transparency and Trust.

Since incorporation in 2009, it has moved up in the industry ranking, with emphasis on its operations in Regulated, Expanding and Emerging markets. We have fulfilled our promise of providing value added products and services to our clients with rewarding partnerships.

National Healthcare Leadership Congress & Awards

Dr Gurpreet Sandhu, CEO and founder of Reva Pharma receiving Pharma Leadership Award endorsed by the World Federation of Healthcare Professionals on 28th September 2019 at the Taj Mahal Hotel, New Delhi.

Since COVID, Biowaste Has Increased By 300 Per Cent

Article Name: 'Since COVID, Biowaste Has Increased By 300 Per Cent'
Updated on: Jul 19, 2020, 20:40 IST
Published By: Anju Maskeri


"Our Mission is to provide Quality Pharmaceutical products and Healthcare services to our global business partners, ensuring highest standards in manufacturing and laboratory practices as well as compliance to Environment, Health and Safety norms. We are bound by our motto: Caring for Healthier Lives.

Our Vision is to be the permanent partner of choice for the products and services that we offer, by creating environment of Reliability, Transparency and Trust."


Our flagship markets are Japan, USA, Germany, Italy and Korea. We hold partnerships and alliances with Innovators, Biological, and Generic organizations the areas of Licensing, CRAM and API’s.

Research & Development

Research and Development is one of the major pillars on which a successful and customer oriented organization is built. We at Reva Pharma view R&D capabilities as a vital component of its ...

Regulatory Accreditations

REVA operates according to current Good Manufacturing and Laboratory Practice (cGMP and GLP). Our API and FDF manufacturing facilities have received regulatory approval from the following major health authorities.


Reva Pharma Monthly Newsletters



Coronavirus Vaccine: $200-Million Decision To Make Untested ...

23 July 2020

New Delhi: The coronavirus vaccine developed at the Oxford University will be in India by November and will ul...

Meet Sarah Gilbert, Oxford’s Coronavirus Vaccine Hunter an...

22 July 2020

On Monday, British vaccinologist Sarah Gilbert and her team at Oxford University leapfrogged towards the finis...

India coronavirus: Nearly One in Four in Delhi Had Covid-19,...

22 July 2020

Nearly one in four residents in India's capital, Delhi, has been exposed to coronavirus infection, antibody te...